Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2017 Feb 12;98(2):438–446. doi: 10.1016/j.ijrobp.2017.02.006

Table 1.

Radiation Oncology-related vs. All Other Class 2 Recall Characteristics

Radiation Oncology Devices (n=502) Other Class 2 Devices (n=9,534) p-value
Year < .001*
2002–2005 15 (3.0) 1,396 (14.6)
2006–2010 162 (32.3) 3,363 (35.3)
2011–2015 325 (64.7) 4,775 (50.1)
Device Product Categories
External Beam 335 (66.7)
Planning System 115 (22.9)
Brachytherapy 42 (8.4)
Simulation System 10 (2.0)
Recall Class < .001*
Class 1 1 (0.2) 424 (4.4)
Class 2 490 (97.6) 8,311 (87.2)
Class 3 11 (2.2) 799 (8.4)
Time Since 510K Clearance (n=471, 8267)
Oldest: Mean # days (range) 2,117 (32 – 10,301) 2,842 (13 – 14,182)
Average: Mean # days (range) 2,294 (43 – 10,301) 2,967 (13 – 14,182) < .001
Newest: Mean # days (range) 2,480 (53 – 12,893) 3,093 (13 – 14,182)
Average: Recalls within 12 months 47 (10.0) 488 (5.9) < .001*
Quantity in Commerce (n=480, 9184) < .001
Mean 682 233,498
Median 107 433
Range 1 – 22,900 0 – 225,000,000
Time to Termination (n=438, 8294) .04
Mean 470.9 497.7
Median 335.5 315
Range 0 – 2,639 0 – 47,46
*

Pearson’s Chi-squared test

Two-sample Kolmogorov-Smirnov test